However, an antitumor role of ALKBH5 has been demonstrated in hepatocellular carcinoma (HCC), pancreatic cancer and non-small cell lung cancer (NSCLC) [39–41]. The gene discussed is ALKBH5; the disease is hepatocellular carcinoma.